LaBrosse Nicole

CIK 00019106621 companySAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001910662

Recent Transactions

50 trades

Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-09-22$78.67/sh−314→ 22,079 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-09-22$77.83/sh−1,913→ 22,393 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Option to Purchase Common Stock
2025-09-10−11,271→ 0 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Option to Purchase Common Stock
2025-09-10−1,135→ 812 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-09-10$12.07/sh+11,271→ 43,171 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-09-10$12.49/sh+1,135→ 44,306 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-09-10$75.93/sh−13,240→ 24,306 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-09-10$75.29/sh−6,760→ 37,546 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-02-23+6,688→ 35,501 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Restricted Stock Units
2025-02-23−6,688→ 20,063 total
Tax Payment
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-02-23$57.75/sh−3,601→ 31,900 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Restricted Stock Units
2025-02-20+21,327→ 21,327 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Option to Purchase Common Stock
2025-02-20+22,603→ 22,603 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Restricted Stock Units
2025-02-16−5,329→ 10,658 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-02-16+5,329→ 31,682 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-02-16+17,409→ 33,402 total
Tax Payment
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-02-16$58.29/sh−9,400→ 24,002 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Restricted Stock Units
2025-02-16−5,093→ 5,093 total
Tax Payment
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-02-16$58.29/sh−2,869→ 28,813 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-02-16+5,093→ 29,095 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Performance Stock Units
2025-02-16−17,409→ 0 total
Tax Payment
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-02-16$58.29/sh−2,742→ 26,353 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Restricted Stock Units
2025-02-15−1,254→ 0 total
Tax Payment
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-02-15$58.29/sh−741→ 15,993 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-02-15+1,254→ 16,734 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Performance Stock Unit
2025-02-12+6,935→ 6,935 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Performance Stock Units
2025-02-12+28,662→ 28,662 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Performance Stock Units
2025-02-12+5,221→ 8,184 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Performance Stock Units
2025-02-12+6,050→ 17,409 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2024-07-22$22.50/sh+4,008→ 19,488 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2024-07-22$22.50/sh+992→ 16,472 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2024-07-22$53.85/sh−4,008→ 15,480 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Option to Purchase Common Stock
2024-07-22−5,000→ 0 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2024-07-22$54.25/sh−992→ 15,480 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2024-06-28$52.04/sh−10,000→ 15,480 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2024-06-28$22.50/sh+10,000→ 25,480 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Option to Purchase Common Stock
2024-06-28−10,000→ 5,000 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2024-06-27$51.93/sh−10,000→ 15,480 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Option to Purchase Common Stock
2024-06-27−10,000→ 15,000 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2024-06-27$22.50/sh+10,000→ 25,480 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2024-06-26$51.82/sh−10,000→ 15,480 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2024-06-26$22.50/sh+10,000→ 25,480 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Option to Purchase Common Stock
2024-06-26−10,000→ 25,000 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Restricted Stock Units
2024-02-23+26,751→ 26,751 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Option to Purchase Common Stock
2024-02-23+27,722→ 27,722 total
Tax Payment
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2024-02-16$36.10/sh−2,737→ 13,015 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Restricted Stock Units
2024-02-16−5,093→ 10,186 total
Tax Payment
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2024-02-16$36.10/sh−2,864→ 15,480 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2024-02-16+5,329→ 18,344 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2024-02-16+5,093→ 15,752 total

Companies

HALOZYME THERAPEUTICS, INC.
SVP, CHIEF FINANCIAL OFFICER
$HALO

Recent Filings

Address

C/O HALOZYME THERAPEUTICS, INC. 12390 EL CAMINO REAL

SAN DIEGO, CA, 92130

View on SEC.gov